
NEOS Surgery wins national award for innovation and digitalisation with Xolomon as a proud technology partner
We are thrilled to celebrate the recent achievement of NEOS Surgery, one of Xolomon’s valued clients, which has been awarded the National Award for Innovation and Digitalisation at the 2024 National SME of the Year Awards, organised by Banco Santander and the Spanish Chamber of Commerce. This prestigious recognition honours
The most read

Why more isn’t always better: Rethinking integration in clinical trials

Xolomon: Empowering clinical research with flexibility and compliance

Xolomon advances lung cancer screening with CASSANDRA Project
Don’t miss the latest news on Xolomon

NEOS Surgery wins national award for innovation and digitalisation with Xolomon as a proud technology partner
We are thrilled to celebrate the recent achievement of NEOS Surgery, one of Xolomon’s valued clients, which has been awarded the National Award for Innovation and Digitalisation at the 2024 National SME of the Year Awards, organised by Banco Santander and the Spanish Chamber of Commerce. This prestigious recognition honours companies that are leading the way in transforming their industries

Why more isn’t always better: Rethinking integration in clinical trials
In today’s digital clinical research landscape, the trend is clear: organizations are investing heavily in integrating multiple digital systems—eCRF, ePRO, CTMS, RTSM, and beyond—to streamline workflows and centralize trial data. The assumption? That the more systems you connect, the better your processes will become. But what if that’s not the case? At Xolomon, we’re taking a different approach. Instead of

Xolomon: Empowering clinical research with flexibility and compliance
In today’s fast-evolving clinical research landscape, electronic data capture (EDC) platforms play a crucial role in ensuring efficiency, accuracy, and compliance. However, many solutions on the market require extensive technical expertise, hidden costs, or lack the adaptability researchers need. At Xolomon, we have designed a powerful, intuitive, and scalable platform that puts control directly in the hands of clinical trial

Xolomon advances lung cancer screening with CASSANDRA Project
Xolomon, a leading technology company specializing in electronic data capture (EDC) solutions, is proud to announce its pivotal role in Spain’s inaugural pilot program for lung cancer screening: the CASSANDRA Project. This initiative underscores Xolomon’s commitment to leveraging technology for public health advancements. Understanding the CASSANDRA Project The CASSANDRA Project, which stands for Cancer Screening, Smoking Cessation, and Respiratory Assessment,